Philippe Paul Juin

8PUBLICATIONS
28CO-AUTHORS
Molecular targetsMechanobiologyCancer cell biologyCancer diagnosisChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 11, 2026
NOXA/MCL-1 axis determines cell-death decision between apoptosis and a GSDME-dependent cell death associated with production of inflammatory cytokines upon treatment of breast cancer cells with antimitotics.

|Nov 22, 2025
Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonism.

Laurent Maillet, Aurélie Fétiveau, Lisenn Lalier

|Aug 26, 2025
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer.

Camille E Tessier, Jennifer Derrien, Aurore M M Dupuy

|Aug 09, 2025
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts.

Chloé C Lefebvre, Philippine Giowachini, Jennifer Derrien

|Oct 27, 2021
An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis.

Molly M Wilson, Céline Callens, Matthieu Le Gallo

|May 12, 2020
Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics.

Steven Lohard, Philippe P Juin, Sophie Barillé-Nion

Pageof 2

Frequent Collaborators

4 joint publications

Sophie Barillé-Nion

2 joint publications

Laurent Maillet

2 joint publications

Vincent J Guen

2 joint publications

Robert A Weinberg